These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27197970)

  • 1. Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands.
    Wapenaar M; Twiss J; Wagenaar M; Seijkens P; van den Toorn L; Stepanous J; Heaney A; van den Bosch A; Boomars KA
    Neth Heart J; 2016 Jun; 24(6):417-424. PubMed ID: 27197970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire.
    Reis A; Twiss J; Vicente M; Gonçalves F; Carvalho L; Meireles J; Melo A; McKenna SP; Almeida L
    Health Qual Life Outcomes; 2016 Jul; 14(1):110. PubMed ID: 27460644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation and validation of the quality of life assessment of the Cambridge pulmonary hypertension outcome review (CAMPHOR) for Brazil.
    Corrêa RA; Pereira MC; Bizzi MF; de Oliveira RWR; Rezende CF; de Oliveira BCMT; Heaney A; McKenna SP; Ribeiro-Oliveira A
    J Patient Rep Outcomes; 2020 Jun; 4(1):43. PubMed ID: 32504261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation and validation of the Cambridge pulmonary hypertension outcome review for Sweden.
    Selimovic N; Rundqvist B; Kjörk E; Viriden J; Twiss J; McKenna SP
    Scand J Public Health; 2012 Dec; 40(8):777-83. PubMed ID: 23117210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The German adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Cima K; Twiss J; Speich R; McKenna SP; Grünig E; Kähler CM; Ehlken N; Treder U; Crawford SR; Huber LC; Ulrich S
    Health Qual Life Outcomes; 2012 Sep; 10():110. PubMed ID: 22971041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-Canadian.
    Coffin D; Duval K; Martel S; Granton J; Lefebvre MC; Meads DM; Twiss J; McKenna SP
    Can Respir J; 2008 Mar; 15(2):77-83. PubMed ID: 18354747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation and Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for Use in Spain.
    Aguirre-Camacho A; Stepanous J; Blanco-Donoso LM; Moreno-Jiménez B; Wilburn J; González-Saiz L; McKenna SP
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):467-473. PubMed ID: 27989660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Polish adaptation of the CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Małaczynska-Rajpold K; Smukowska-Gorynia A; Heaney A; McKenna SP; Janus M; Araszkiewicz A; Jankiewicz S; Slawek-Szmyt S; Tomaszewska I; Mularek-Kubzdela T
    Cardiol J; 2020; 27(5):608-615. PubMed ID: 30338844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAPTATION AND VALIDATION OF THE CAMBRIDGE PULMONARY HYPERTENSION OUTCOME REVIEW (CAMPHOR) FOR CROATIA.
    Hećimović A; Heaney A; McKenna SP; Basara L; Jakopović M; Vukić Dugac A; Redžepi G; Rotim C; Samaržija M; Jokić-Begić N; Popović-Grle S
    Acta Clin Croat; 2019 Mar; 58(1):3-12. PubMed ID: 31363319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population.
    Ganderton L; Jenkins S; McKenna SP; Gain K; Fowler R; Twiss J; Gabbay E
    Respirology; 2011 Nov; 16(8):1235-40. PubMed ID: 21810146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-cultural adaptation of the Cambridge Pulmonary Hypertension Outcome Review for use in patients with pulmonary hypertension in Colombia.
    Villaquirán C; Moreno S; Dueñas R; Acuña P; Lutz JR; Wilburn J; Heaney A
    J Bras Pneumol; 2019 Jul; 45(6):e20180332. PubMed ID: 31365733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
    Gomberg-Maitland M; Thenappan T; Rizvi K; Chandra S; Meads DM; McKenna SP
    J Heart Lung Transplant; 2008 Jan; 27(1):124-30. PubMed ID: 18187098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.
    McKenna SP; Doughty N; Meads DM; Doward LC; Pepke-Zaba J
    Qual Life Res; 2006 Feb; 15(1):103-15. PubMed ID: 16411035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation, cross-cultural adaptation and validation of the Osteoarthritis Quality of Life (OAQoL) questionnaire for use in Portugal.
    Gomes JL; Águeda AF; Heaney A; Duarte C; Lopes C; Costa T; Marona J; Rodrigues-Manica S; Maia S; Costa M; Branco JC; McKenna SP; Barcelos A; Pimentel-Santos FM
    Rheumatol Int; 2019 Apr; 39(4):715-722. PubMed ID: 30415453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.
    Dhaenens BAE; van Dijk SA; Taal W; Noordhoek DC; Coffey A; McKenna SP; Oostenbrink R
    J Patient Rep Outcomes; 2024 Mar; 8(1):33. PubMed ID: 38499890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation and validation of the greek Psoriatic Arthritis Quality of Life Scale.
    Heaney Α; Stepanous J; McKenna SP; Athanassiou P; Vidalis AA
    Psychiatriki; 2017; 28(3):219-225. PubMed ID: 29072185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients.
    Bonner N; Abetz L; Meunier J; Sikirica M; Mathai SC
    Health Qual Life Outcomes; 2013 Oct; 11():161. PubMed ID: 24088389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension.
    Twiss J; McKenna S; Ganderton L; Jenkins S; Ben-L'amri M; Gain K; Fowler R; Gabbay E
    BMC Pulm Med; 2013 Jul; 13():45. PubMed ID: 23844640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of the adapted Dutch version of the revised Scoliosis Research Society 22-item questionnaire.
    Schlösser TP; Stadhouder A; Schimmel JJ; Lehr AM; van der Heijden GJ; Castelein RM
    Spine J; 2014 Aug; 14(8):1663-72. PubMed ID: 24360746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?
    Martínez Meñaca A; Blanco Vich I; López Meseguer M; López Reyes R; Bedate Díaz P; Elías Hernández T; Fernández-Cuesta Peñafiel I; Fernández G; Álvez Liste A; Escribano Subías P
    Adv Ther; 2021 Apr; 38(4):1860-1875. PubMed ID: 33675523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.